Vident Investment Advisory’s BioNTech BNTX Stock Holding History

Vident Investment Advisory’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,565	Closed	-$1.46M	–	147
2023 Q2	$1.46M	Sell	13,565 -3,466	-20%	-$390K	0.05%	393
2023 Q1	$2.12M	Buy	17,031 +12,650	+289%	+$1.74M	0.07%	323
2022 Q4	$658K	Sell	4,381 -448	-9%	-$68.9K	0.02%	618
2022 Q3	$632K	Sell	4,829 -282	-6%	-$43.1K	0.02%	717
2022 Q2	$761K	Buy	+5,111	New	+$781K	0.02%	718
2021 Q3	–	Sell	-9,096	Closed	-$2.04M	–	1165
2021 Q2	$2.04M	Sell	9,096 -12,880	-59%	-$2.43M	0.06%	402
2021 Q1	$2.4M	Buy	21,976 +2,023	+10%	+$215K	0.08%	288
2020 Q4	$1.63M	Sell	19,953 -9,338	-32%	-$917K	0.07%	369
2020 Q3	$2.03M	Sell	29,291 -1,496	-5%	-$107K	0.1%	214
2020 Q2	$2.06M	Sell	30,787 -19,832	-39%	-$990K	0.11%	186
2020 Q1	$2.96M	Sell	50,619 -1,298	-3%	-$50.5K	0.19%	98
2019 Q4	$1.76M	Buy	+51,917	New	+$1.16M	0.11%	288

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Vident Investment Advisory's BNTX Position: Q3 2023 in Review

Vident Investment Advisory sold out of BioNTech (BNTX) in Q3 2023, closing a stake of 13,565 shares — an estimated $1.46M sold.

Vident Investment Advisory first reported a position in BNTX in Q4 2019 and held it in 12 quarters. The position peaked at $2.96M in Q1 2020. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

Vident Investment Advisory reported no remaining BioNTech position as of Q3 2023 after selling out during the quarter.
Vident Investment Advisory sold 13,565 BioNTech shares in Q3 2023, an estimated $1.46M.
Vident Investment Advisory first reported a position in BioNTech in Q4 2019 and held it in 12 quarters.
Vident Investment Advisory's BioNTech position peaked at $2.96M in Q1 2020.
252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.